Daily Dose - Apr 29th, 2026
Daily Dose |
View online
April 29, 2026
CMC for cell and gene therapies remains a ‘learning curve’ for Big Pharma
For large pharmaceutical companies, the chemistry, manufacturing, and control (CMC) process is a key constraint compared to conventional therapies.
Read More
Thermo Fisher opens US bioprocess design center in Massachusetts
The 4,000-square-foot facility in Plainville will offer hands-on bioprocessing support to help accelerate biologics development and scale-up.
Read More
CellProthera, Quintessence partner on cell therapy manufacturing
The collaboration will focus on improving cell sorting, yield and process efficiency for stroke therapies.
Read More